TRANSLATE BIO, INC.

TBIO NASDAQ
9.72
-0.01
-0.10%
Closed 17:53 07/17 EDT
Open
9.74
Prev Close
9.73
High
9.84
Low
9.50
Volume
51.95K
Avg Vol (3M)
210.05K
52 Week High
16.60
52 Week Low
4.810
% Turnover
0.12%
Market Cap
419.20M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers TRANSLATE BIO, INC. TBIO stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Translate Bio, Inc. is a messenger RNA, or mRNA, therapeutics company. The Company is developing medicines to treat diseases caused by protein or gene dysfunction. The Company is using its proprietary mRNA therapeutic platform, or MRT platform, and it create mRNA that encodes functional proteins. The mRNA is delivered to the target cell where the cell’s own machinery recognizes it and translates it, restoring or augmenting protein function to treat or prevent disease. The MRT product candidate for the lung, MRT5005, is designed to address the underlying cause of CF by delivering mRNA encoding fully functional CFTR protein to the lung epithelial cells through nebulization.
MORE >

Recently

Name
Price
%Change